Angela DeVeaugh-Geiss
Overview
Explore the profile of Angela DeVeaugh-Geiss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rockhill K, Bau G, DeVeaugh-Geiss A, Chilcoat H, Dart R, Iwanicki J, et al.
J Am Coll Emerg Physicians Open
. 2024 Oct;
5(5):e13338.
PMID: 39449817
Objective: Opioid overdose survivors present to emergency departments (EDs) and many EDs have developed programs to initiate buprenorphine. The impact of the increasing use of buprenorphine in ED and by...
2.
Keith D, Tegge A, Stein J, Athamneh L, Craft W, Chilcoat H, et al.
J Addict Med
. 2023 Jun;
17(3):e156-e163.
PMID: 37267169
Objectives: Individuals in recovery from opioid use disorder (OUD) are vulnerable to the impacts of the COVID-19 pandemic. Recent findings suggest increased relapse risk and overdose linked to COVID-19-related stressors....
3.
Craft W, Shin H, Tegge A, Keith D, Athamneh L, Stein J, et al.
Addiction
. 2022 Dec;
118(5):890-900.
PMID: 36524904
Background And Aims: Limited information exists regarding individual subgroups of recovery from opioid use disorder (OUD) following treatment and how these subgroups may relate to recovery trajectories. We used multi-dimensional...
4.
Craft W, Tegge A, Keith D, Shin H, Williams J, Athamneh L, et al.
Drug Alcohol Depend
. 2022 Nov;
241:109687.
PMID: 36334989
No abstract available.
5.
Craft W, Tegge A, Keith D, Shin H, Williams J, Athamneh L, et al.
Drug Alcohol Depend
. 2022 Mar;
234:109389.
PMID: 35287034
Background: Opioid use disorder (OUD) seriously impacts public health in the United States. However, few investigations of long-term outcomes following treatment with medication for OUD exist. Additionally, these studies have...
6.
Gryczynski J, Lee J, Dusek K, McDonald R, Sharma A, Malone M, et al.
J Subst Abuse Treat
. 2021 Jun;
127:108349.
PMID: 34134866
Buprenorphine, an effective treatment for opioid use disorder (OUD), remains underutilized in many U.S. jails and prisons. However, use of non-prescribed (i.e., diverted) buprenorphine has been reported in these settings....
7.
Monico L, Gryczynski J, Lee J, Dusek K, McDonald R, Malone M, et al.
J Subst Abuse Treat
. 2021 Feb;
123:108267.
PMID: 33612198
Background: Buprenorphine treatment remains unavailable in many jails and prisons, but use of nonprescribed (i.e., diverted) buprenorphine has been reported in these settings. The purpose of this analysis is to...
8.
Carrell D, Albertson-Junkans L, Ramaprasan A, Scull G, Mackwood M, Johnson E, et al.
J Drug Assess
. 2020 Jun;
9(1):97-105.
PMID: 32489718
Opioid surveillance in response to the opioid epidemic will benefit from scalable, automated algorithms for identifying patients with clinically documented signs of problem prescription opioid use. Existing algorithms lack accuracy....
9.
Coplan P, Cepeda M, Petronis K, DeVeaugh-Geiss A, Barsdorf A, Kern D, et al.
Postgrad Med
. 2019 Nov;
132(1):44-51.
PMID: 31721609
: Among patients with chronic pain using long-term opioid therapy, the incidence of opioid abuse, addiction, overdose, and associated death are not well quantified. The range of estimates for these...
10.
Hazlehurst B, Green C, Perrin N, Brandes J, Carrell D, Baer A, et al.
Pharmacoepidemiol Drug Saf
. 2019 Jun;
28(8):1143-1151.
PMID: 31218780
Purpose: To enhance automated methods for accurately identifying opioid-related overdoses and classifying types of overdose using electronic health record (EHR) databases. Methods: We developed a natural language processing (NLP) software...